Your browser doesn't support javascript.
loading
Effect of Anti-Glutamate Antibodies in Modeled Parkinsonian Syndrome.
Kucheryanu, V G; Vetrile, L A; Zakharova, I A; Voronina, N A.
Affiliation
  • Kucheryanu VG; Research Institute of General Pathology and Pathophysiology, Moscow, Russia. kucheryanu@mail.ru.
  • Vetrile LA; Research Institute of General Pathology and Pathophysiology, Moscow, Russia.
  • Zakharova IA; Research Institute of General Pathology and Pathophysiology, Moscow, Russia.
  • Voronina NA; Research Institute of General Pathology and Pathophysiology, Moscow, Russia.
Bull Exp Biol Med ; 169(4): 431-434, 2020 Aug.
Article in En | MEDLINE | ID: mdl-32889565

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dopamine / Hypokinesia / Glutamic Acid / Parkinsonian Disorders / Antibodies / Antiparkinson Agents Limits: Animals Language: En Journal: Bull Exp Biol Med Year: 2020 Type: Article Affiliation country: RUSSIA

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dopamine / Hypokinesia / Glutamic Acid / Parkinsonian Disorders / Antibodies / Antiparkinson Agents Limits: Animals Language: En Journal: Bull Exp Biol Med Year: 2020 Type: Article Affiliation country: RUSSIA